Correction to: Scientific Reports https://doi.org/10.1038/s41598-018-31055-8, published online 18 September 2018
This Article contains errors in the Results and Discussion section, Figures 3, 4 and 7, the legends of Figures 2 and 7, as well as the Supplementary Information.
In the Results and Discussion section, under the subheading ‘Application to human disease’,
“The array detected a total of 66 amines in human plasma. Our method can quantify 42 individual amines (see Supplementary Table 3). Of these 42, 1-methylhistidine, 3-methylhistidine and glutathione did not produce reliable results due to variabilities in their standard curves (r2 value < 0.95), which could be attributed to poor peak shapes when processed.”
should read:
“The array detected a total of 65 amines in human plasma. Our method can quantify 41 individual amines (see Supplementary Table 3). Of these 41, 1-methylhistidine, 3-methylhistidine and glutathione did not produce reliable results due to variabilities in their standard curves (r2 value < 0.95), which could be attributed to poor peak shapes when processed.”
“Results from the 39 quantifiable amines (Fig. 3), across all time points (Fig. 3), were processed using principal components analysis (PCA) as an unsupervised approach to establish data clustering and outliers, based on peak areas (Fig. 4A).”
should read:
“Results from the 38 quantifiable amines (Fig. 3), across all time points (Fig. 3), were processed using principal components analysis (PCA) as an unsupervised approach to establish data clustering and outliers, based on peak areas (Fig. 4A).”
“Finally, in order to extract the maximum amount of information from our data, PCA and PLS-DA were also performed using the peak areas of all 42 amines, including 1-methylhistidine, 3-methylhistidine and glutathione (Supplementary Fig. 1).”
should read:
“Finally, in order to extract the maximum amount of information from our data, PCA and PLS-DA were also performed using the peak areas of all 41 amines, including 1-methylhistidine, 3-methylhistidine and glutathione (Supplementary Fig. 1).”
Under the subheading ‘Supervised analysis of amino acids/methylarginines of interest and associated ratios’,
“We next performed supervised analysis of the 39 analytes quantified and found that 26 were significantly altered at one or more of the time points post-surgery (Fig. 3; Supplementary Table 3), with most of them showing a reduction in levels (Fig. 3; Supplementary Table 3).”
should read:
“We next performed supervised analysis of the 38 analytes quantified and found that 25 were significantly altered at one or more of the time points post-surgery (Fig. 3; Supplementary Table 3), with most of them showing a reduction in levels (Fig. 3; Supplementary Table 3).”
“Of the pathways reduced following bypass surgery all 8 (ADMA, L-NMMA, SDMA, arginine, glutamine, glutamic acid, citrulline and ornithine) of the amino acids and methylarginines associated (directly or indirectly) with the NOS pathway were included (Fig. 5).”
should read:
“Of the pathways reduced following bypass surgery amino acids and methylarginines associated (directly or indirectly) with the NOS pathway were included (Fig. 5).”
Under the subheading ‘Methylarginines and methylarginine: arginine ratios’, the following sentence should be deleted: “However, our analytical method shows that plasma L-NMMA concentrations are actually substantially higher than ADMA at all assessed time points (Fig. 7).”
“We found that similarly to arginine, ADMA and L-NMMA, but not SDMA, were reduced at two or more time points after surgery. The concerted changes in arginine and methylarginine concentrations did not significantly alter ADMA: arginine ratio but did increase L-NMMA: arginine and SDMA: arginine ratios after bypass surgery.”
should read:
“We found that similarly to arginine, ADMA but not SDMA, was reduced at two or more time points after surgery. The concerted changes in arginine and methylarginine concentrations did not significantly alter ADMA: arginine ratio but did increase SDMA: arginine ratios after bypass surgery.”
“iNOS activity was reduced at 24 and 48 h after surgery which coincides with reduced arginine and increased L-NMMA: arginine ratio (Fig. 7).”
should read:
“iNOS activity was reduced at 24 and 48 h after surgery which coincides with reduced arginine (Fig. 7).”
In the legend of Figure 2, the following sentence should be added: “It is important to note that LNMMA and homoarginine share the same molecular weight and MS parameters. Under the experimental conditions reported in this paper, they can only be distinguished using chromatographic retention time.”
In addition, in Figures 3, 4 and 7, the analysis of LNMMA should be removed. The correct Figures and accompanying legends appear below.
In the Supplementary Information, the analysis of LNMMA should be removed from Supplementary Figure 1 as well as Supplementary Tables 3 and 4. The correct Supplementary Figure 1 and Supplementary Tables 3 and 4 as well as accompanying legends appear below.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ahmetaj-Shala, B., Olanipekun, M., Tesfai, A. et al. Author Correction: Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping. Sci Rep 14, 11800 (2024). https://doi.org/10.1038/s41598-024-59923-6
Published:
DOI: https://doi.org/10.1038/s41598-024-59923-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.